This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Late-Onset Hypersensitivity Reaction With Leukopenia and Thrombocytopenia Induced by Oxcarbazepine Treatment in a Patient With Schizoaffective Disorder

Yi-Wei Yeh, MD; Tzu-Yun Wang, MD; Chang-Chih Huang, MD; and Yi-Chyan Chen, MD, PhD

Published: March 18, 2008

Article Abstract

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Oxcarbazepine is an anticonvulsant with similar chemicalstructure to carbamazepine.1 Oxcarbazepine is not only effectivein epileptic therapy, but also useful in the treatmentof refractory bipolar and schizoaffective disorders.1-5 Comparedto carbamazepine, rare hematologic suppression side-effect hadbeen reported with oxcarbazepine treatment.6-8‘ ‹


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 69

Quick Links: Schizophrenia and Schizoaffective Disorders

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...